Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0305441 METHOD FOR PRODUCING ANTIBODIES USING OVINE B-CELLS AND USES THEREOF
Herein is reported a cultivation system for cultivating a pool of ovine B-cells or single deposited ovine B-cells in the presence of phorbol myristate acetate...
2018/0305440 GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES
Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.
2018/0305439 METHODS AND COMPOSITIONS FOR MODIFIED FACTOR IX FUSION PROTEINS
The present invention provides Factor IX fusion proteins with higher specific activity and a longer useful clotting function relative to wild type or...
2018/0305438 BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density and strength. In certain...
2018/0305437 NEW POLYPEPTIDE
The present disclosure relates to a class of engineered polypeptides having a binding affinity for programmed death-ligand 1 (PD-L1), and provides a PD-L1...
2018/0305436 LIGANDS OF B7H RECEPTOR IN THE TREATMENT OF OSTEOPENIA AND OSTEOPOROSIS
A novel use of ligands of B7h receptor in the treatment of osteoporosis or osteopenia is disclosed as well as the use of B7h receptor as target for the...
2018/0305435 Engineering Antiviral T Cell Immunity through Stem Cells and Chimeric Antigen Receptors
The HIV-specific cytotoxic T lymphocyte (CTL) response is a critical component in controlling HIV replication and is an important part of the ultimate failure...
2018/0305434 ENGINEERING T CELL RECEPTORS
The use of model T cell receptors (TCRs) as scaffolds for in vitro engineering of novel specificities is provided. TCRs with de novo binding to a specific...
2018/0305433 Cell
The present invention relates to a cell which co-expresses a first chimeric antigen receptor (CAR) and second CAR at the cell surface, each CAR comprising: (i)...
2018/0305432 TCR AND USES THEREOF
The present invention relates to a TCR or functional variant thereof having antigenic specificity for CD1c molecules associated with a self-lipid, preferably...
2018/0305431 Novel Insulin Derivatives and the Medical Uses Hereof
The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel...
2018/0305430 Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including once weekly administration. The...
2018/0305429 RECOMBINANT CANCER THERAPEUTIC CYTOKINE
Recombinant therapeutic cytokines ("therakines") for the treatment of cancer are provided. The recombinant therakines include a truncated region of MDA-7/TL-24...
2018/0305428 LONG-ACTING FGF21 FUSION PROTEINS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
The present invention provides a fusion protein comprising an FGF21 mutant protein and an Fc region of an immunoglobulin. The fusion protein according to the...
2018/0305427 FOLLISTATIN-RELATED FUSION PROTEINS AND USES THEREOF
In certain aspects, the present disclosure provides compositions and methods for inhibiting activity of TGF.beta. superfamily ligands, particularly ligands...
2018/0305426 CANCER-SPECIFIC SUICIDE GENE FOR CELL-BASED AND GENE THERAPY
The present invention provides pluripotent and multipotent stem cells, including embryonic stem cells, induced pluripotent stem cells, adult stem cells and...
2018/0305425 Factor H-Fc Immunotheraphy
Fusion proteins comprising human FH domains 18-20 (FH18-20) linked via an optional linker to IgG Fc, wherein the FH has mutation of D to G at position 1119 in...
2018/0305424 Methods of Inducibly Targeting Chromatin Effectors and Compositions for Use in the Same
Methods of inducibly targeting a chromatin effector to a genomic locus are provided. Aspects of the methods include employing a chemical inducer of proximity...
2018/0305423 UBIQUITIN INTERACTING MOTIF PEPTIDES AS THERAPEUTICS
The present disclosure describes the use peptides of comprising ubiquitin interacting motifs (UIMs) alone or in combination with other agents to treat...
2018/0305421 Follistatin in Treating Duchenne Muscular Dystrophy
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD)....
2018/0305420 MODIFIED TAMM-HORSFALL PROTEIN AND RELATED COMPOSITIONS AND METHODS OF USE
Embodiments of the present disclosure provide polypeptides, related materials and compositions, and methods for their use. In certain embodiments, the present...
2018/0305419 Polypeptides and Antibodies to Treat Skin Conditions Associated with Overproduction of Sebum
The present application provides compositions, methods, and uses of polypeptide or antibody inhibitors of insig-1 ubiquitination for preventing or treating...
2018/0305418 THERMOCONDUCTIVE MATERIAL, HEAT SINK, HEAT SPREADER, METHOD FOR PRODUCING HEAT SPREADER, AND METHOD FOR...
Disclosed is a thermoconductive material comprising a protein and having a thermal conductivity of more than 0.6 W/(mK). Also disclosed is a method for...
2018/0305417 HIGH-EFFICIENCY, SODIUM-SPECIFIC, BLUE-SHIFTED CHANNELRHODOPSINS
Methods and compositions used to identify and characterize a new channelrhodopsin derived from algae which is highly efficient, sodium specific and...
2018/0305416 Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof
Recombinant Mycobacteria (rMyc) which contain sequences encoding a heparin-binding hemagglutinin (HBHA) fission protein are provided, as are methods of making...
2018/0305415 IMMUNOGENIC FUSION PROTEIN
The present invention relates to an immunogenic fusion protein comprising a first amino acid sequence having at least 80% sequence identity with the amino acid...
2018/0305414 IMMUNOGLOBULIN-BINDING POLYPEPTIDE
An object of the present invention is to provide a polypeptide having a high binding capacity for an immunoglobulin kappa chain, and having excellent alkali...
2018/0305413 Methods for Extracting Phycocyanin
Methods for extracting phycocyanin from biomass, comprising suspending dried biomass in a buffer solution, separating the biomass from supernatant, including...
2018/0305412 COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE
A multipartite peptide that inhibits release of exosomes in a cell, comprising an N-terminal end and a C-terminal end and comprising at least one secretion...
2018/0305411 N-TERMINAL DELETED GP120 IMMUNOGENS
The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using...
2018/0305410 PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
A new species of circovirus, porcine circovirus type 3 (PCV3), was identified from sows with clinical symptoms normally associated with porcine circovirus type...
2018/0305409 MULTI-TARGET COMPOUND WITH ANTICOAGULATION AND ANTIPLATELET ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF
Provided is a multi-target compound with anticoagulation and platelet GPIIb/IIIa receptor antagonism. The formula of the multi-target compound is as follows:...
2018/0305408 COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF
The present disclosure provides a cyclic peptide, or a variant or analog thereof, or a cyclic peptidomimetic, with between 15 and 35 amino acids, having a...
2018/0305407 IMMUNOTHERAPY TARGETING OF THE SHARED ABNORMAL CONFORMATIONAL STATE OF AMYLOIDOGENIC PEPTIDES/PROTEINS
The present invention is directed to pharmaceutical agents and compositions useful for the treatment and prevention of amyloid disease in a subject. The...
2018/0305406 Melanocortin Receptor Ligands
The present invention is directed to compounds according to formula, (R.sup.2R.sup.3)-A.sup.1-c(A.sup.2-A.sup.3-A.sup.4-A.sup.5-A.sup.6-A.sup- ...
2018/0305405 CONJUGATES OF RGD PEPTIDES AND PORPHYRIN OR (BACTERIO)CHLOROPHYLL PHOTOSYNTHESIZERS AND THEIR USES
Conjugates of porphyrin, chlorophyll and bacteriochlorophyll photosensitizers with RGD-containing peptides or RGD peptidomimetics are provided that are useful...
2018/0305404 NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues,...
2018/0305403 PPAR AGONISTS AND METHODS OF USE THEREOF
Provided herein are deuterated compounds and compositions useful in increasing PPAR.delta. activity. The compounds have a formula ##STR00001## where L.sup.5...
2018/0305402 ANTIMICROBIAL COMPOUNDS AND/OR MODULATORS OF MICROBIAL INFECTIONS AND METHODS OF USING THE SAME
Some embodiments include compounds that can inhibit the growth of bacterial and/or inhibit or reduce microbial infections caused by one or more microorganisms...
2018/0305401 PROCESSES FOR PURIFYING PROTEINS FROM PLASMA
The invention provides processes for producing preparations (e.g., plasma preparations or fibrinogen (Fg)-depleted preparations) containing one or more...
2018/0305400 STABILIZED COMPOUNDS HAVING SECONDARY STRUCTURE MOTIFS
The present invention provides novel stabilized crosslinked compounds having secondary structure motifs, libraries of these novel compounds, and methods for...
2018/0305399 FUROSTAN-3-OL DERIVATIVES AS SKELETAL MUSCLE HYPERTROPHIC AGENTS
Compounds of formula I ##STR00001## are disclosed. The compounds are useful for promoting skeletal muscle hypertrophy or treating skeletal muscle atrophy.
2018/0305398 C-3 NOVEL TRITERPENONE WITH C-28 UREA DERIVATIVES AS HIV INHIBITORS
The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically...
2018/0305397 Preparation and Uses of Obeticholic Acid
The present invention relates to obeticholic acid: ##STR00001## or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic acid...
2018/0305396 DEUTERATED COMPOUNDS
Compounds of general formula (I) wherein (I) RI-R4 are each independently selected from H and deuterium; and at least one of RI-R4 is deuterium. The compounds...
2018/0305395 METHODS FOR THE PREPARATION OF DEOXYCHOLIC ACID, AND INTERMEDIATES USEFUL IN THE PREPARATION OF DEOXYCHOLIC ACID
The present invention relates to new and improved processes for the preparation of deoxycholic acid (DCA) and pharmaceutically acceptable salts thereof, as...
2018/0305394 OXYSTEROL-THERAPEUTIC AGENT DERIVATIVE FOR BONE HEALING
Oxysterol-therapeutic agent derivatives or OXY133-therapeutic agent derivative compounds and methods of synthesizing the same are provided for use in promoting...
2018/0305393 PHOSPHATE REPLACEMENT MRNA CAP ANALOGS
The present disclosure relates to cap analogs, which can result in high levels of capping efficiency and transcription and improved translation efficiencies....
2018/0305392 Oligonucleotide Conjugation Process
The present invention relates to the field of oligonucleotide conjugates and to methods of synthesis thereof. In the present method a low-water content solvent...
2018/0305391 COFACTOR ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER
Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structure ##STR00001## They are useful in the treatment of cancer...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.